DrugDashboards

Glycopyrrolate

Glycopyrrolate · GLYCOPYRROLATE .2 mg/mL · Injection · Intramuscular; Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1487-03 · 25 POUCH in 1 BOX / 1 VIAL in 1 POUCH / 1 mL in 1 VIAL · ANDA · View full market →

The short version

24 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.3650per billing unit (0.1 MG)HCPCS J1596 · Jul 1, 2026
  • Part D plans paid (avg)$0.9615per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 0.1 MG
$0.365
HCPCS J1596 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for glycopyrrolate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $42.13 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA090963
TE code
AP
Approval date
Sep 21, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJun 6, 2023
    HF Acquisition Co LLC — Labeling: Label Mix-up

Manufacturers of Glycopyrrolate (Injection)

LabelerStrengthFirst seenLast seen
Accord Healthcare, Inc.,GLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Solco Healthcare US, LLCGLYCOPYRROLATE .4 mg/2mLJul 15, 2026Sep 3, 2026
Solco Healthcare US, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Somerset Therapeutics, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Xiromed LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Xiromed, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCGLYCOPYRROLATE 4 mg/20mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCGLYCOPYRROLATE .4 mg/2mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCGLYCOPYRROLATE 1 mg/5mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.GLYCOPYRROLATE 4 mg/20mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.GLYCOPYRROLATE 1 mg/5mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.GLYCOPYRROLATE .4 mg/2mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedGLYCOPYRROLATE 4 mg/20mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedGLYCOPYRROLATE .4 mg/2mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedGLYCOPYRROLATE 1 mg/5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstGLYCOPYRROLATE 1 mg/5mLJul 15, 2026Sep 2, 2026
Jvet Pharmaceuticals LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncGLYCOPYRROLATE 4 mg/20mLJul 15, 2026Sep 2, 2026
Sandoz IncGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncGLYCOPYRROLATE .4 mg/2mLJul 15, 2026Sep 2, 2026
Sandoz IncGLYCOPYRROLATE 1 mg/5mLJul 15, 2026Sep 2, 2026
Xiromed LlcGLYCOPYRROLATE .2 mg/mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Aug 31, 2026
Meitheal Pharmaceuticals Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Aug 31, 2026
Nivagen Pharmaceuticals, Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Aug 31, 2026
Fresenius Kabi USA, LLCGLYCOPYRROLATE .2 mg/mLJul 15, 2026Aug 29, 2026
Alembic Pharmaceuticals Inc.GLYCOPYRROLATE .2 mg/mLJul 15, 2026Aug 28, 2026
Medical Purchasing Solutions, LLCGLYCOPYRROLATE 4 mg/20mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Glycopyrrolate — NDC 51662-1487-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662148703.

Free to cite with attribution — see how the data is put together.